Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
22
pubmed:dateCreated
2010-10-18
pubmed:abstractText
In the present study we demonstrated that neurotoxin MPP(+)-induced DNA damage is followed by ataxia telangiectasia muted (ATM) activation either in cerebellar granule cells (CGC) or in B65 cell line. In CGC, the selective ATM inhibitor KU-55933 showed neuroprotective effects against MPP(+)-induced neuronal cell loss and apoptosis, lending support to the key role of ATM in experimental models of Parkinson's disease. Likewise, we showed that knockdown of ATM levels in neuroblastoma B65 cells using an ATM-specific siRNA attenuates the phosphorylation of retinoblastoma protein without affecting other cell-cycle proteins involved in the G(0)/G(1) cell-cycle phase. Moreover, we demonstrated DNA damage, in human brain samples of PD patients. These findings support a model in which MPP(+) leads to ATM activation with a subsequent DNA damage response and activation of pRb. Therefore, this study demonstrates a new link between DNA damage by MPP(+) and cell-cycle re-entry through retinoblastoma protein phosphorylation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1420-9071
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3865-82
pubmed:dateRevised
2011-11-2
pubmed:meshHeading
pubmed-meshheading:20502937-1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, pubmed-meshheading:20502937-Aged, pubmed-meshheading:20502937-Aged, 80 and over, pubmed-meshheading:20502937-Animals, pubmed-meshheading:20502937-Apoptosis, pubmed-meshheading:20502937-Brain, pubmed-meshheading:20502937-Cell Cycle, pubmed-meshheading:20502937-Cell Cycle Proteins, pubmed-meshheading:20502937-Cell Line, pubmed-meshheading:20502937-Cells, Cultured, pubmed-meshheading:20502937-Cerebellum, pubmed-meshheading:20502937-DNA Damage, pubmed-meshheading:20502937-DNA-Binding Proteins, pubmed-meshheading:20502937-Female, pubmed-meshheading:20502937-Humans, pubmed-meshheading:20502937-Male, pubmed-meshheading:20502937-Middle Aged, pubmed-meshheading:20502937-Morpholines, pubmed-meshheading:20502937-Neurotoxins, pubmed-meshheading:20502937-Parkinson Disease, pubmed-meshheading:20502937-Protein-Serine-Threonine Kinases, pubmed-meshheading:20502937-Pyrones, pubmed-meshheading:20502937-Rats, pubmed-meshheading:20502937-Rats, Sprague-Dawley, pubmed-meshheading:20502937-Tumor Suppressor Proteins
pubmed:year
2010
pubmed:articleTitle
Activation of ataxia telangiectasia muted under experimental models and human Parkinson's disease.
pubmed:affiliation
Institut de Biomedicina, Centros de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Universitat de Barcelona, Spain. camins@ub.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't